Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 983 products on this category.

Product data	Purity	Price range	Estimated delivery
Lenvatinib Impurity 49 REF: 4Z-L-124055	- - -	To inquire	Tue 17 Dec 24
Gimeracil Impurity 21 REF: 4Z-G-047026CAS: 149143-67-9	- - -	To inquire	Tue 17 Dec 24
N-Nitroso Palbociclib Impurity 43 REF: 4Z-P-196088	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 38 REF: 4Z-N-066056	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 23 REF: 4Z-E-068036CAS: 1013025-04-1	- - -	To inquire	Tue 17 Dec 24
Abiraterone Impurity 24 REF: 4Z-A-8265CAS: 90468-14-7	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 31 REF: 4Z-N-066048CAS: 22323-80-4	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 26 REF: 4Z-E-068039CAS: 320-47-8	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 35 REF: 4Z-N-066052CAS: 1038972-16-5	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 47 REF: 4Z-N-066065CAS: 1253768-91-0	- - -	To inquire	Tue 17 Dec 24
Tamoxifen EP Impurity C REF: 4Z-T-0115CAS: 15917-65-4	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 30 REF: 4Z-N-066047CAS: 66148-15-0	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 46 REF: 4Z-E-068059CAS: 1798807-39-2	- - -	To inquire	Tue 17 Dec 24
Nintedanib Impurity 21 REF: 4Z-N-066035CAS: 1912-30-7	- - -	To inquire	Tue 17 Dec 24
Olaparib Impurity 39 REF: 4Z-O-032044CAS: 126702-17-8	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 28 REF: 4Z-E-068041CAS: 1187368-66-6	- - -	To inquire	Tue 17 Dec 24
Carfilzomib Impurity 80 REF: 4Z-C-121085CAS: 868540-15-2	- - -	To inquire	Tue 17 Dec 24
Enzalutamide Impurity 49 REF: 4Z-E-068062CAS: 888072-96-6	- - -	To inquire	Tue 17 Dec 24
Lenvatinib Impurity 23 REF: 4Z-L-124028	- - -	To inquire	Tue 17 Dec 24
Lenvatinib Impurity 48 REF: 4Z-L-124054	- - -	To inquire	Tue 17 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Lenvatinib Impurity 49

Ref: 4Z-L-124055

Gimeracil Impurity 21

Ref: 4Z-G-047026

N-Nitroso Palbociclib Impurity 43

Ref: 4Z-P-196088

Nintedanib Impurity 38

Ref: 4Z-N-066056

Enzalutamide Impurity 23

Ref: 4Z-E-068036

Abiraterone Impurity 24

Ref: 4Z-A-8265

Nintedanib Impurity 31

Ref: 4Z-N-066048

Enzalutamide Impurity 26

Ref: 4Z-E-068039

Nintedanib Impurity 35

Ref: 4Z-N-066052

Nintedanib Impurity 47

Ref: 4Z-N-066065

Tamoxifen EP Impurity C

Ref: 4Z-T-0115

Nintedanib Impurity 30

Ref: 4Z-N-066047

Enzalutamide Impurity 46

Ref: 4Z-E-068059

Nintedanib Impurity 21

Ref: 4Z-N-066035

Olaparib Impurity 39

Ref: 4Z-O-032044

Enzalutamide Impurity 28

Ref: 4Z-E-068041

Carfilzomib Impurity 80

Ref: 4Z-C-121085

Enzalutamide Impurity 49

Ref: 4Z-E-068062

Lenvatinib Impurity 23

Ref: 4Z-L-124028

Lenvatinib Impurity 48

Ref: 4Z-L-124054